The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
diatrizoate meglumine · Injection, Solution
3 marketed package NDCs · 1 active manufacturer
Same drug class
Other molecules FDA puts in Radiographic Contrast Agent, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- air 90% carbon dioxide 10%· 1 maker
- carbon dioxide air· 1 maker
- carbon dioxide air mixture· 1 maker
- carbon dioxide nitrogen· 1 maker
- carbon dioxide-air mixture· 1 maker
- carbon dioxide-oxygen mixture· 1 maker
- carbon dioxide-oxygen-nitrogen mixture· 1 maker
- carbon dioxide, oxygen· 1 maker
- cell energy performance drops· 1 maker
- iopromide· 1 maker
- iothalamate meglumine· 1 maker
- oxygen-carbon dioxide mixture· 1 maker
Common questions
- Is Diatrizoate meglumine in shortage right now?
- No. FDA does not currently list Diatrizoate meglumine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Diatrizoate meglumine?
- 4 companies have marketed Diatrizoate meglumine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.